Jan 09, 2023 / 05:45PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone. I'm Robbie Marcus, the medtech analyst at JPMorgan. I'm happy to introduce our next company, Baxter. Joe Almeida, the CEO, is going to come up and do a presentation, then we'll do some question-and-answer afterwards. Joe?
Jose E. Almeida - Baxter International Inc. - Chairman of the Board, President & CEO
Thank you, Robbie. Good morning, everyone. It's a pleasure to be here with you today, and I would like to just start by the safe harbor statement. Please take your time. And Baxter is a 100-year-old company that has a history of technology in health care, they have spanned in every continent over more than 120 countries.
Baxter is transforming itself. Here today, I'm going to cover some aspects of this transformation. We are recognized as employers, it is not only for our social responsibility, but also for what we have done to improve lives and society. Baxter treats 350 million patients a year. Over 300,000 patients depend on us every single day in
Baxter International Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers